Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization
In conclusion, our study identifies telomerase as a promising therapeutic target for treating neovascular disease of the eye and thus provides a proof of principle for further exploration of telomerase inhibition as a novel treatment strategy for nvAMD.PMID:38582267 | DOI:10.1016/j.bbadis.2024.167156
Source: Biochimica et Biophysica Acta - Category: Biochemistry Authors: Aman Kumar Yosuke Nagasaka Vinodhini Jayananthan Asmaa Zidan Tyler Heisler-Taylor Jayakrishna Ambati Shigeo Tamiya Nagaraj Kerur Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Biochemistry | Blindness | Genetics | Opthalmology | Statistics | Study